Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |